You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LYEL Sale Disclosure
Aguirre Jarrad Mattieu · SEC Form 4 · Filed Oct 13, 2026
Sale
Calculated transaction value
$3.64K
Aguirre Jarrad Mattieu Chief Medical Officer
LYEL
Lyell Immunopharma
LYEL
Transaction date
Oct 12, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 1 day later
LYEL daily price context
Close on/before transaction
$8.27
Oct 12, 2026
First close after public filing
$7.99
Oct 14, 2026
Return after filing · so far
+111.01%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 422 shares @ $8.63
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002150331-26-000003
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$3.64K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Sale | Oct 12, 2026 | $3.64K |